지속적 복막투석(CAPD) 시장 규모, 점유율, 성장 분석 : 제품 유형별, 투석법별, 환자 유형별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market size was valued at USD 9.5 Billion in 2024 and is poised to grow from USD 10.05 Billion in 2025 to USD 15.78 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global market for Continuous Ambulatory Peritoneal Dialysis (CAPD) is significantly influenced by the increasing prevalence of chronic kidney disease and the growing preference for home-based therapies. CAPD enables patients to manage their treatment independently throughout the day, enhancing lifestyle flexibility and minimizing hospital visits, which is crucial for overloaded healthcare systems. The market has transitioned from manual solutions to advanced fluid formulations and catheter designs while integrating educational programs to facilitate broader access. Cost containment pressures coupled with technological innovations, such as telehealth monitoring and improved materials, support CAPD's adoption by reducing complications and enhancing patient outcomes. Furthermore, AI technologies are revolutionizing adherence and outcomes through remote monitoring and personalized patient support, paving the way for more proactive, patient-centered care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market Segments Analysis

Global continuous ambulatory peritoneal dialysis (capd) market is segmented by product type, dialysis modality, patient type, end users, distribution channel and region. Based on product type, the market is segmented into Capd Solutions and Capd Equipment & Accessories. Based on dialysis modality, the market is segmented into Traditional CAPD and Automated CAPD (APD). Based on patient type, the market is segmented into Adult Patients, Pediatric Patients and Geriatric Patients. Based on end users, the market is segmented into Hospitals, Dialysis Centers (Independent), Home Healthcare Settings, Specialty Clinics and Others. Based on distribution channel, the market is segmented into Online and Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The growing incidence of chronic kidney disease is significantly increasing the number of patients in need of dialysis, which in turn drives demand for convenient, home-based treatment options like continuous ambulatory peritoneal dialysis (CAPD). As healthcare systems move towards outpatient care, both clinicians and patients favor solutions that promote independence and lower reliance on medical facilities. This shift fosters investments in training, supplies, and supportive services to enhance the accessibility and acceptance of CAPD. Consequently, the market experiences expansion as more patients seek the convenience of home treatments, while providers focus on effective capacity management and improving continuity of care.

Restraints in the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The Global Continuous Ambulatory Peritoneal Dialysis (CAPD) market faces significant challenges due to insufficient and fragmented reimbursement systems for home dialysis services and supplies. This lack of consistent coverage creates financial uncertainty for both patients and providers, leading to reluctance in opting for CAPD. Healthcare providers may be unwilling to invest resources into the necessary training and home support without assured payment pathways, while suppliers deal with unpredictable market access. Consequently, this situation hinders clinician recommendations and patient acceptance, limits investment in service networks, and impedes the development of essential infrastructure necessary for the broader adoption of CAPD in various healthcare environments.

Market Trends of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The Global Continuous Ambulatory Peritoneal Dialysis (CAPD) market is witnessing a significant trend towards home-based care, driven by a growing preference among providers and patients for peritoneal dialysis modalities that facilitate treatment outside traditional healthcare settings. This shift is fueling investments in patient education and nursing support programs, along with efforts to simplify device designs for enhanced usability. Payers and health systems are prioritizing continuity of care, reduced hospital dependence, and improved patient quality of life, leading to increased collaborations aimed at optimizing training and supply logistics. Manufacturers are responding by enhancing the portability and convenience of consumables, thus promoting decentralized delivery models, bolstering caregiver engagement, and fostering integrated care pathways that align clinical outcomes with a patient-centered approach.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Capd Solutions
  • Standard Dextrose Solutions
  • Icodextrin Solutions
  • Amino Acid Solutions
• Capd Equipment & Accessories
  • Catheters
  • Transfer Sets
  • Connectors
  • Other Accessories

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Dialysis Modality & CAGR (2026-2033)

• Market Overview
• Traditional CAPD
• Automated CAPD (APD)

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adult Patients
• Pediatric Patients
• Geriatric Patients

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Hospitals
• Dialysis Centers (Independent)
• Home Healthcare Settings
• Specialty Clinics
• Others

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Online
• Offline

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size & CAGR (2026-2033)

• North America (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDX, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Health Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dialysis Clinic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gambro AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NxStage Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DaVita Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbot Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polymedicure Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renal Services Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations